ONLINE DATABASE SEARCH - HIV-LS-290-MEMO
1. 42869 HIV-LS-290; EMBASE-HIV-2/25/2004
The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin*1, *2
Dussart, Sylvie, Courcoul, Marianne, Bessou, Gilles, Douaisi, Marc, Duverger, Yohann, Vigne, Robert, and Decroly, Etienne
Biochemical and Biophysical Research Communications 2004. 315(1): 66-72
HYPERLINK: http://www.sciencedirect.com/science/article/B6WBK-4BJW268-3/2/cbfd383697ccf6eb7f95236335c7f33e
2. 42870 HIV-LS-290; PUBMED-HIV-2/25/2004
Potent Nonclassical Nucleoside Antiviral Drugs Based on the N,N-Diarylformamidine Concept
Anastasi, C, Hantz, O, De Clercq, E, Pannecouque, C, Clayette, P, Dereuddre-Bosquet, N, Dormont, D, Gondois-Rey, F, Hirsch, I, and Kraus, JL
J Med Chem 2004. 47(5): 1183-1192
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14971898&dopt=abstract
3. 42871 HIV-LS-290; EMBASE-HIV-2/25/2004
Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains
Miller, John F, Furfine, Eric S, Hanlon, Mary H, Hazen, Richard J, Ray, John A, Robinson, Laurence, Samano, Vicente, and Spaltenstein, Andrew
Bioorganic & Medicinal Chemistry Letters 2004. 14(4): 959-963
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BH63MS-7/2/b42a0f4892f981972c4f8c5eac036b73
4. 42872 HIV-LS-290; PUBMED-HIV-2/25/2004
Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1
Chan, JH, Freeman, GA, Tidwell, JH, Romines, KR, Schaller, LT, Cowan, JR, Gonzales, SS, Lowell, GS, Andrews, III CW, Reynolds, DJ, St, Clair M, Hazen, RJ, Ferris, RG, Creech, KL, Roberts, GB, Short, SA, Weaver, K, Koszalka, GW, and Boone, LR
J Med Chem 2004. 47(5): 1175-82
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14971897&dopt=abstract
5. 42873 HIV-LS-290; PUBMED-HIV-2/25/2004
Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry
Witvrouw, M, Pannecouque, C, Fikkert, V, Hantson, A, Van Remoortel, B, Hezareh, M, De Clercq, E, and Brown, SJ
Antivir Chem Chemother 2003. 14(6): 321-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14968938&dopt=abstract
6. 42874 HIV-LS-290; EMBASE-HIV-2/25/2004
Structure-based Drug Design Targeting an Inactive RNA Conformation: Exploiting the Flexibility of HIV-1 TAR RNA*1
Murchie, Alastair IH, Davis, Ben, Isel, Catherine, Afshar, Mohammad, Drysdale, Martin J, Bower, Justin, Potter, Andrew J, Starkey, Ian D, Swarbrick, Terry M, and Mirza, Shabana
Journal of Molecular Biology 2004. 336(3): 625-638
HYPERLINK: http://www.sciencedirect.com/science/article/B6WK7-4BBH5CC-1/2/428750903befa86793fafe47bb5b19f1
7. 42875 HIV-LS-290; PUBMED-HIV-2/25/2004
Mode of Action for Linear Peptide Inhibitors of HIV-1 gp120 Interactions
Biorn, AC, Cocklin, S, Madani, N, Si, Z, Ivanovic, T, Samanen, J, Van Ryk, DI, Pantophlet, R, Burton, DR, Freire, E, Sodroski, J, and Chaiken, IM
Biochemistry 2004. 43(7): 1928-1938
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14967033&dopt=abstract
8. 42876 HIV-LS-290; EMBASE-HIV-2/25/2004
A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor
Montembault, Mickael, Vo-Thanh, Giang, Deyine, Abdallah, Fargeas, Valerie, Villieras, Monique, Adjou, Ane, Dubreuil, Didier, Esquieu, Didier, Gregoire, Catherine, and Opi, Sandrine
Bioorganic & Medicinal Chemistry Letters 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BMC7GM-9/2/816108622c6a7f4707ac0883a7ebf279
9. 42877 HIV-LS-290; EMBASE-HIV-2/25/2004
Quantitative real-time PCR on Lightcycler(R) for the detection of human immunodeficiency virus type 2 (HIV-2)
Ruelle, Jean, Mukadi, Benoit Kabamba, Schutten, Martin, and Goubau, Patrick
Journal of Virological Methods 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T96-4BM8KFH-3/2/ab3223f676c4021e7f6ad4c538c26438
10. 42878 HIV-LS-290; PUBMED-HIV-2/25/2004
Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates
Bulgheroni, E, Citterio, P, Croce, F, Lo, Cicero M, Vigano, O, Soster, F, Chou, TC, Galli, M, and Rusconi, S
J Antimicrob Chemother 2004. 53(3): 464-468
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14963061&dopt=abstract
11. 42879 HIV-LS-290; EMBASE-HIV-2/25/2004
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus
Aquaro, Stefano, Guenci, Tania, Santo, Fabiola Di, Francesconi, Mauro, Calio, Raffaele, and Perno, Carlo Federico
Antiviral Research 2004. 61(2): 133-137
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-49WPBVK-1/2/3c415a8acfbb4615543d15d5cdcf77f0
12. 42880 HIV-LS-290; PUBMED-HIV-2/25/2004
Design and synthesis of a template-assembled oligomannose cluster as an epitope mimic for human HIV-neutralizing antibody 2G12
Li, H and Wang, LX
Org Biomol Chem 2004. 2(4): 483-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14770226&dopt=abstract
13. 42881 HIV-LS-290; PUBMED-HIV-2/25/2004
Tannin inhibits HIV-1 entry by targeting gp41
Lu, L, Liu, SW, Jiang, SB, and Wu, SG
Acta Pharmacol Sin 2004. 25(2): 213-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14769212&dopt=abstract
14. 42882 HIV-LS-290; PUBMED-HIV-2/25/2004
Inhibition of HIV-1 Replication in Monocyte-Derived Macrophages by Mycobacterium tuberculosis
Goletti, D, Carrara, S, Vincenti, D, Giacomini, E, Fattorini, L, Garbuglia, AR, Capobianchi, MR, Alonzi, T, Fimia, GM, Federico, M, Poli, G, and Coccia, E
J Infect Dis 2004. 189(4): 624-33
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14767815&dopt=abstract
15. 42883 HIV-LS-290; EMBASE-HIV-2/25/2004
HIV-1 entry inhibitor entrances
Kuhmann, Shawn E and Moore, John P
Trends in Pharmacological Sciences 2004. 25(3): 117-120
HYPERLINK: http://www.sciencedirect.com/science/article/B6T1K-4BM8YTY-2/2/fd1b82557c0c74c1eb1df42015ef37dd
16. 42884 HIV-LS-290; PUBMED-HIV-2/25/2004
HIV-1 Vpr Induces Defects in Mitosis, Cytokinesis, Nuclear Structure, and Centrosomes
Chang, F, Re, F, Sebastian, S, Sazer, S, and Luban, J
Mol Biol Cell 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14767062&dopt=abstract
17. 42885 HIV-LS-290; EMBASE-HIV-2/25/2004
Efficacy of two modalities of triple HIV therapy: probable superiority of indinavir
Eiros Bouza, JM, Ortega, M, de Lejarazu, ROrtiz, Blanco, R, Bachiller, P, and de Luis, DA
International Journal of Antimicrobial Agents 2004. 23(3): 303-305
HYPERLINK: http://www.sciencedirect.com/science/article/B6T7H-4BN0J57-8/2/31734c25d03a4f294818c6839d34821e
18. 42886 HIV-LS-290; EMBASE-HIV-2/25/2004
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA
Mischiati, Carlo, Finotti, Alessia, Sereni, Alessia, Boschetti, Sindi, Baraldi, Pier Giovanni, Romagnoli, Romeo, Feriotto, Giordana, Jeang, Kuan-Teh, Bianchi, Nicoletta, Borgatti, Monica, and Gambari, Roberto
Biochemical Pharmacology 2004. 67(3): 401-410
HYPERLINK: http://www.sciencedirect.com/science/article/B6T4P-4BRCNCP-3/2/f9cf7272f21dd4b21f3558568e53d075
19. 42887 HIV-LS-290; EMBASE-HIV-2/25/2004
Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120
Chiba, Harumi, Inokoshi, Junji, Nakashima, Hideki, Omura, Satoshi, and Tanaka, Haruo
Biochemical and Biophysical Research Communications 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WBK-4BS0D6C-B/2/4b869d3db670d50f79ee72fcee4347b5
20. 42888 HIV-LS-290; EMBASE-HIV-2/25/2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains
Shen, Dong-Ming, Shu, Min, Mills, Sander G, Chapman, Kevin T, Malkowitz, Lorraine, Springer, Martin S, Gould, Sandra L, DeMartino, Julie A, Siciliano, Salvatore J, and Kwei, Gloria Y
Bioorganic & Medicinal Chemistry Letters 2004. 14(4): 935-939
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BF0CYW-2/2/8e11bd5ea7118aeb5b61cb8a1546d145
21. 42889 HIV-LS-290; EMBASE-HIV-2/25/2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds
Shen, Dong-Ming, Shu, Min, Willoughby, Christopher A, Shah, Shrenik, Lynch, Christopher L, Hale, Jeffrey J, Mills, Sander G, Chapman, Kevin T, Malkowitz, Lorraine, and Springer, Martin S
Bioorganic & Medicinal Chemistry Letters 2004. 14(4): 941-945
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BF0CYW-3/2/c3814d4f4f8b25072fabc7b3f549fc42
22. 42890 HIV-LS-290; EMBASE-HIV-2/25/2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment
Shu, Min, Loebach, Jennifer L, Parker, Kerry A, Mills, Sander G, Chapman, Kevin T, Shen, Dong-Ming, Malkowitz, Lorraine, Springer, Martin S, Gould, Sandra L, and DeMartino, Julie A
Bioorganic & Medicinal Chemistry Letters 2004. 14(4): 947-952
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BF0CYW-4/2/49ba8e9c3f15fbaa56a46b1cf53abd32
23. 42891 HIV-LS-290; PUBMED-HIV-2/25/2004
Comparative study of non nucleoside inhibitors with HIV-1 reverse transcriptase based on 3D-QSAR and docking
Chen, HF, Yao, XJ, Li, Q, Yuan, SG, Panaye, A, Doucet, JP, and Fan, BT
SAR QSAR Environ Res 2003. 14(5-6): 455-74
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14758988&dopt=abstract
24. 42892 HIV-LS-290; EMBASE-HIV-2/25/2004
Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives
Yoakim, C, Bonneau, PR, Deziel, R, Doyon, L, Duan, J, Guse, I, Landry, S, Malenfant, E, Naud, J, and Ogilvie, WW
Bioorganic & Medicinal Chemistry Letters 2004. 14(3): 739-742
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4B7Y52H-7/2/dc6a254e7dbae1f2829f68da29fb547c
25. 42893 HIV-LS-290; PUBMED-HIV-2/25/2004
Resistance to HIV-1 entry inhibitors
Olson, WC and Maddon, PJ
Curr Drug Targets Infect Disord 2003. 3(4): 283-94
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14754430&dopt=abstract
26. 42894 HIV-LS-290; EMBASE-HIV-2/25/2004
Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against Adenovirus
Uckun, Fatih M, Pendergrass, Sharon, Qazi, Sanjive, Samuel, P, and Venkatachalam, TK
European Journal of Medicinal Chemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VKY-4BMTN9N-3/2/0e5189b149fe3ff633c503bb474c0f3a
27. 42895 HIV-LS-290; PUBMED-HIV-2/25/2004
The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions
Baraz, L and Kotler, M
Curr Med Chem 2004. 11(2): 221-231
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14754418&dopt=abstract
28. 42896 HIV-LS-290; EMBASE-HIV-2/25/2004
HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity
Bruder, Cornelia, Hagleitner, Magdalena, Darlington, Gretchen, Mohsenipour, Iradj, Wurzner, Reinhard, Hollmuller, Isolde, Stoiber, Heribert, Lass-Florl, Cornelia, Dierich, Manfred P, and Speth, Cornelia
Molecular Immunology 2004. 40(13): 949-961
HYPERLINK: http://www.sciencedirect.com/science/article/B6T9R-4B7HGX7-2/2/0127ef95606aae415c57c38ed0f79582
29. 42897 HIV-LS-290; PUBMED-HIV-2/25/2004
Different resistance mutations can be detected simultaneously in the blood and the lung of HIV-1 infected individuals on antiretroviral therapy
White, NC, Israel-Biet, D, Coker, RJ, Mitchell, DM, Weber, JN, and Clarke, JR
J Med Virol 2004. 72(3): 352-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14748057&dopt=abstract
30. 42898 HIV-LS-290; EMBASE-HIV-2/25/2004
A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics
Sadaie, MReza, Mayner, Ronald, and Doniger, Jay
Antiviral Research 2004. 61(1): 1-18
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-49Y4064-2/2/c1bb4665d0932990e6fe9361be47c36d
31. 42899 HIV-LS-290; EMBASE-HIV-2/25/2004
Anti-HIV-1 activity of pyrryl aryl sulfone (PAS) derivatives: synthesis and SAR studies of novel esters and amides at the position 2 of the pyrrole nucleus
Silvestri, Romano, Artico, Marino, La Regina, Giuseppe, De Martino, Gabriella, La Colla, Massimiliano, Loddo, Roberta, and La Colla, Paolo
Il Farmaco 2004. 59(3): 201-210
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJ8-4BP3TT5-3/2/42429d250ad0e320cd5e2456025b9ca5
32. 42900 HIV-LS-290; EMBASE-HIV-2/25/2004
Synthesis of - and -apio nucleoside analogues with 2'-hydroxyl group as potential anti-HIV agents
Jin, Dong Zhe, Kwon, Sung Hee, Moon, Hyung Ryong, Gunaga, Prashantha, Kim, Hea Ok, Kim, Dae-Kee, Chun, Moon Woo, and Jeong, Lak Shin
Bioorganic & Medicinal Chemistry 2004. 12(5): 1101-1109
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4BRJ47V-10/2/ada87e9f276bc9879cacf2b4bc22977d
33. 42901 HIV-LS-290; EMBASE-HIV-2/25/2004
Synthesis of 6-arylvinyl analogues of the HIV drugs SJ-3366 and Emivirine
Wamberg, Michael, Pedersen, Erik B, El-Brollosy, Nasser R, and Nielsen, Claus
Bioorganic & Medicinal Chemistry 2004. 12(5): 1141-1149
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4BRJ47V-14/2/ec7640aec635bfd17806847ebb53a063
34. 42902 HIV-LS-290; WOS-HIV-2/15/2004
CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines
Ito, Y, Grivel, JC, Chen, S, Kiselyeva, Y, Reichelderfer, P, and Margolis, L
J INFECT DIS 2004. 189(3): 506-514
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188467900019
35. 42903 HIV-LS-290; WOS-HIV-2/15/2004
Structural investigation of 3,5-disubstituted isoxazoles by H-1-nuclear magnetic resonance
Sechi, M, Sannia, L, Orecchioni, M, Carta, F, Paglietti, G, and Neamati, N
J HETEROCYCLIC CHEM 2003. 40(6): 1097-1102
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188322600021
36. 42904 HIV-LS-290; WOS-HIV-2/15/2004
Enumeration of latently infected CD4(+) T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay
Fondere, JM, Planas, JF, Huguet, MF, Baillat, V, Bolos, F, Reynes, J, and Vendrell, JP
J CLIN VIROL 2004. 29(1): 33-38
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188289000006
37. 42905 HIV-LS-290; WOS-HIV-2/15/2004
A highly flexible route to 1,2,3,4,5,6-hexahydro-5-hydroxypyrimidin-2-one as potential HIV protease inhibitors
Enders, D, Wortmann, L, Raabe, G, and Ducker, B
HETEROCYCLES 2004. 62: 559-581
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188256600048
38. 42906 HIV-LS-290; WOS-HIV-2/15/2004
An improved microtiter assay for evaluating anti-HIV-I neutralizing antibodies from sera or plasma
Zhang, CY, Chen, YY, and Ben, KL
BMC INFECT DIS 2003. 3: art. no.-30
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188425300001
39. 42907 HIV-LS-290; WOS-HIV-2/15/2004
Synthesis, anti-HIV-1 activity study of Keggin type heteropoly blues containing glycine
Liu, SX, Wang, EB, Zhai, HJ, Han, ZB, Zeng, Y, and Li, ZL
ACTA CHIM SINICA 2004. 62(2): 170-175
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188418600012
40. 42908 HIV-LS-290; WOS-HIV-2/22/2004
Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or Simian immunodeficiency virus Nef are resistant to cyclosporine treatment
Khan, M, Jin, LL, Huang, MB, Miles, L, Bond, VC, and Powell, MD
J VIROL 2004. 78(4): 1843-1850
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188662900023
41. 42909 HIV-LS-290; WOS-HIV-2/22/2004
3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors
Ungwitayatorn, H, Samee, W, and Pimthon, J
J MOL STRUCT 2004. 689(1-2): 99-106
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188589200012
42. 42910 HIV-LS-290; WOS-HIV-2/22/2004
Differential anti-HIV activity of distinct hydroalcoholic Hypericum perforatum preparations.
Willbrand, CT, Hodgson, A, Clanton, DJ, Ho, RJ, and Wenner, CA
J INVEST MED 2004. 52(1): S140
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188254600371
43. 42911 HIV-LS-290; WOS-HIV-2/22/2004
Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542
Jacobson, JM, Israel, RJ, Lowy, I, Ostrow, NA, Vassilatos, LS, Barish, M, Tran, DNH, Sullivan, BM, Ketas, TJ, O'Neill, TJ, Nagashima, KA, Huang, W, Petropoulos, CJ, Moore, JP, Maddon, PJ, and Olson, WC
ANTIMICROB AGENTS CH 2004. 48(2): 423-429
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188592200009
44. 42912 HIV-LS-290; WOS-HIV-2/22/2004
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1
Parkin, NT, Hellmann, NS, Whitcomb, JM, Kiss, L, Chappey, C, and Petropoulos, CJ
ANTIMICROB AGENTS CH 2004. 48(2): 437-443
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188592200011